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re searchers and prac tising clin icians, 
but to state positive diagnostic criteria 
without exclusion cri teria could be 
mis leading.
For instance, a 45-year-old woman 
with a 12 pack-year history of smoking 
and high C-reactive protein secondary 
to asymptomatic thyroiditis might 
receive a diagnosis of chronic systemic 
inﬂ ammatory syndrome according 
to Fabbri and Rabe’s proposed set of 
criteria. Furthermore, the diagnosis 
of heart failure is quite problematic 
in older people as well as in obese 
patients and those with respiratory 
disease.2–4 Thus, coexisting  heart 
failure and COPD, mainly in older 
and obese patients, creates a true 
diagnostic conundrum aﬀ ecting the 
accuracy of the ﬁ nal diagnosis. 
Further complicating the issue is the 
ﬁ nding that metabolic syndrome as so-
ciates more with restrictive than with 
obstructive lung dysfunction in older 
people.5 Accordingly, although we 
share and reinforce Fabbri and Rabe’s 
rec om mendation for a comprehensive 
and not purely respiratory view 
and care of patients with COPD, we 
think that available know ledge pre-
vents us from develop ing a reliable 
diagnostic index of chronic systemic 
inﬂ ammatory syn drome.
Thus, the core value of Fabbri and 
Rabe’s Viewpoint lies in the promotion 
of a new clinical and research approach 
to COPD. Such an approach should 
translate into a systematic and multi-
disciplinary eﬀ ort to categorise, on 
solid scientiﬁ c bases and in a practical 
perspective, the chronic syndrome that 
characterises most patients with COPD.
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The Sept 1 issue of The Lancet was 
important for raising awareness of 
chronic obstructive pulmonary disease 
(COPD). None of the articles, however, 
refers to the fact that around 90% of 
COPD patients are managed solely by 
general practitioners.1,2 
The transfer of new scientiﬁ c insights 
to primary care is crucial. For example, 
as Leonardo Fabbri and Klaus Rabe 
point out,3 pulmonary and systemic 
COPD manifestations aﬀ ect progno sis. 
In a survey of 75 of about 150 general 
practitioners attending a continuing 
medical education conference in 
Lucerne, Switzerland, in June, 2006, 
we found that participants knew that 
assessment of patients with COPD 
should not be restricted to the lungs 
(table). For example, 71% routinely 
enquired about physical activity, the 
latter being associated with severe 
exacerbations and death.4 However, 
they did not seem to be aware that vari-
ables other than lung function are of 
key importance for good prognostica-
tion. 28% of general practitioners said 
they had heard of the BODE index5 
but none of them was able to list any 
of its four components (body-mass 
index [B], degree of airﬂ ow obstruc tion 
[O] and functional dyspnoea [D], and 
exercise capacity [E]).
Following examples from cardio-
vascular medicine (eg, the PROCAM 
score), COPD research should provide 
a composite prognostic score (predict-
ing, for example, the risk of severe 
exacerbations). Such a score must be 
based on methodologically sound 
derivation and validation studies and 
feasibility considerations in primary 
care. A systematic risk assessment 
of patients in primary care is likely to 
bring about more individually tailored 
COPD management.
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Number of 
GPs (n=75)
Routine assessments
Smoking status 75 (100%)
Physical activity 53 (70·7%)
History of exacerbations 50 (66·7%)
Social environment 43 (57·3%)
Body-mass index 41 (54·7%)
Vaccination status 29 (38·7%)
Dyspnoea score 29 (38·7%)
Depressive symptoms 14 (18·7%)
Ergometry 5 (6·7%)
Blood gases 2 (2·7%)
Fat free mass 1 (1·3%)
6-min walk test 1 (1·3%)
Assessment of prognosis
Based on spirometry 35 (46·7%)
Other parameters (history of 
exacerbations, dyspnoea)
21 (28·0%)
None 19 (25·3%)
Awareness of BODE index
None 54 (72·0%)
Heard of 21 (28·0%)
Know any of the 4 parameters 0
Basis of treatment selection
Clinical experience 56 (74·7%)
Guidelines 46 (61·3%)
Continuing medical education 44 (58·7%)
Patient’s prognosis 18 (24·0%)
Table: Self-reported routine assessments for 
COPD by Swiss general practitioners
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Authors’ reply
As we had hoped, discussion of our 
proposal to regard COPD as a disease 
that aﬀ ects several organ systems 
has begun. A paper by Young and 
colleagues1 suggested that lung 
volumes, such as reduced forced 
expiratory volume in 1 s (FEV1), 
can serve as a marker of premature 
death when assessing baseline risk 
of chronic obstructive pulmonary 
disease, lung cancer, coronary artery 
disease, and stroke, collectively 
accounting for 70–80% of premature 
deaths in smokers. Also, a reduced 
FEV1 can identify undiagnosed 
COPD, and has a similar use to that 
of serum cholesterol in assessing 
cardiovascular risk; it deﬁ nes smokers 
at greatest risk of lung cancer, and 
might represent a marker that 
identiﬁ es smokers at greatest need of 
medical intervention.
Conceptually we will therefore also 
have to reconsider the traditional 
spirometric classiﬁ cations of severity 
of COPD, considering not only that it 
should include the other components 
of chronic systemic inﬂ ammatory 
syndrome outlined in our Viewpoint, 
but also that the levels of FEV1 might 
be used for classiﬁ cation of severity 
of other chronic diseases, particularly 
cardiovascular disease and metabolic 
syndrome.2
In identifying factors that con-
stitute the basis of chronic systemic 
inﬂ ammatory syndrome as a diagnosis, 
we were guided by the available 
published evidence, and conceded 
that this list might not be exhaustive 
and suggested that our syndromic 
approach be tested prospectively in 
clinical trials. In this sense we welcome 
the comments of Raﬀ aele Incalzi and 
Claudio Pedone, who correctly highlight 
some of the diﬃ  culties in the clinical 
presentation of patients with chronic 
heart failure and obesity. However, we 
believe that it is probably not helpful 
to start a multidisciplinary approach 
such as ours by highlighting the more 
unusual presentations, although they 
admittedly might, on an individual 
basis, make a diagnosis diﬃ  cult.
As Milo Puhan and colleagues 
correctly state, most COPD patients are 
seen in primary care and the limited 
information they provide from a group 
of Swiss general practitioners suggests 
that there is a general recognition 
in primary care that COPD aﬀ ects 
several aspects of physical and mental 
health, but that the available tools 
for prognostication and acceptable 
standards of care are still lacking.
We agree with Incalzi and Pedone 
that some value of our article lies in 
the promotion of a new clinical and 
research approach to COPD, but we 
also think that the available evidence 
so far allows for designing these trials 
right away to further increase our 
knowledge base; we believe that these 
trials need to be done urgently. Our 
call for a multidisciplinary approach 
obviously also needs to involve the 
primary-care sector and, as Puhan and 
colleagues correctly point out, it needs 
to be based on methodologically sound 
studies for validation and feasibility 
in several sectors of health care and in 
diﬀ erent health-care settings.
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Beyrer C. Burma and the challenge of humanitarian 
assistance. Lancet 2007; 370: 1465–67—In this 
Comment (Oct 27), the ﬁ fth sentence of the 
fourth paragraph should have read: “And the 
restrictions imposed by the junta, which led to 
the withdrawal of the Global Fund and the 
French section of Médecins Sans Frontières, and 
caused the International Committee of the Red 
Cross to suspend many ﬁ eld operations, remain 
barriers to providing relief for the suﬀ ering.2”
Currey B, Quamruzzaman Q, Rahman M. Can the 
WHO Ministerial Forum lead to the eradication of 
TB? Lancet 2007; 370: 1401–03—In this 
Comment (Oct 20), the second sentence of the 
ﬁ gure’s sublegend should have read: 
“Tuberculosis infection numbers were 
142·3 million (WHO Americas region, white, 
about 18% of total population), 130·2 million 
(WHO European region, green, about 15%), and 
1583·4 million (rest of world, red, about 38%).” 
The words “in 2005” had been incorrectly 
added.
Appeal for Basra 
Children’s Hospital
Many doctors, nurses, and others have 
felt desperately that they want to help 
in Iraq. Now, at last, we have a chance.
Eva-Maria Hobiger, an oncologist in 
a Viennese children’s hospital, runs a 
humanitarian project called Aladdin’s 
Magic Lamp, which supports a children’s 
hospital in Basra by sending medicines 
and medical equipment, and by help ing 
with building repairs and training.
Please send donations to the founder 
of “4Basra”, which links with Aladdin’s 
Magic Lamp, to: John Reynolds, 9 
Upper Mount Street, Dublin 2, Ireland. 
Donations can also be made via PayPal. 
To reduce work load, receipts will not 
be sent unless specially requested, but 
the names of all donors will be posted 
on the website unless anonymity is 
speciﬁ cally asked for.
If we can help save one child or 
relieve one parent or grandparent it 
will all be worth it. We cannot walk by 
on the other side.
Supporters include Denis J Haliday, Alexander Macara, 
and Jack Piachaud. I declare that I have no conﬂ ict of 
interest. 
Chris Burns-Cox
chris.burns-cox@virgin.net
Southend Farm, Wootton under Edge GL12 7PB, UK
For the 4Basra website see 
http://4basra.org/
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